<p><img src="https://imageproxy.pbkrs.com/https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2026/01/CTA-22-01-2026-shutterstock_2589155789-419x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="419" height="241" original-src="https://imageproxy.pbkrs.com/https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2026/01/CTA-22-01-2026-shutterstock_2589155789-419x241.jpg"/></p>
<p>该交易包括采用互补的技术平台和实践，以提高开发过程中的效率和可见性。图片来源：PeopleImages / Shutterstock.com。</p>
<p>Worldwide Clinical Trials 已达成最终协议，收购肿瘤学合同研究组织（CRO）Catalyst Clinical Research。</p>
<p>此次交易将使 Catalyst 董事会主席 Nick Dyer 加入 Worldwide 的董事会，而 Catalyst 总裁兼首席执行官 Nik Morton 将成为 Worldwide 执行领导团队的一部分。</p>
<p>此次收购旨在将 Worldwide 建立为一家专注于肿瘤学的 CRO，同时在多个治疗领域保持深度，并扩大其在临床试验中的全球覆盖范围。</p>
<p><img src="https://imageproxy.pbkrs.com/https://hubspot-pmisites.pantheonsite.io/techmonitor/wp-content/themes/goodlife-wp-B2B/assets/images/icons/Module.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="130" height="183" original-src="https://imageproxy.pbkrs.com/https://hubspot-pmisites.pantheonsite.io/techmonitor/wp-content/themes/goodlife-wp-B2B/assets/images/icons/Module.png"/></p>
<p>免费样本</p>
<h3>下载精选报告的样本页面</h3>
<p>探索我们为您精心挑选的报告样本，提前预览其中的见解。今天就下载您的免费副本。</p>
<p>此次整合将 Catalyst 的解决方案 Catalyst Flex 和 Catalyst Oncology 与 Worldwide 现有的产品组合相结合，为客户提供全面服务、功能性服务提供商（FSP）资源和混合模型的扩展服务。</p>
<p>此外，该交易还包括采用互补的技术平台和运营实践，以提高开发生命周期中的数据效率和可见性。</p>
<p>Worldwide 将以未披露的金额收购 Catalyst，待满足常规的成交条件和监管批准。预计交易将在 2026 年第一季度完成。</p>
<p>Worldwide 得到了 Kohlberg 的支持，而 Catalyst 是 QHP Capital 的投资组合公司。BofA Securities 独家为 Catalyst 提供咨询；Smith Anderson 是其法律顾问。Greenberg Traurig 为 Worldwide 提供法律顾问。</p>
<p>Worldwide 首席执行官 Alistair Macdonald 表示：“将 Worldwide 和 Catalyst 结合在一起提升了我们在肿瘤学领域的能力，并为我们共同的客户提供了新的解决方案。</p>
<p>“我们很高兴将 Catalyst 深厚的运营专业知识和肿瘤学信誉与我们知名的中枢神经系统专业 CRO 能力相结合，创造出一个差异化的生物技术导向的肿瘤学解决方案。我们的共同客户寻求专注的高级管理人员的联系和关注、可预测性、速度、灵活性和科学严谨性。</p>
<p>“他们将受益于可扩展的 FSP 模型的增加，该模型集成了本土/离岸服务线，同时我们利用先进的业务管理工具和人工智能推动运营卓越。”</p>
<p>在 2024 年 5 月，Medidata 宣布与 Worldwide 扩大合作关系，以加快临床试验并提升患者体验。</p>
<h3>在 GlobalData 报告上解锁高达 35% 的折扣</h3>
<p>在报告商店结账时使用代码</p>
<ul>
<li>
<h3>20% 折扣</h3>
</li>
</ul>
<p>购买 2 份报告</p>
<p>使用代码：</p>
<h4>Bundle20</h4>
<ul>
<li>
<h3>25% 折扣</h3>
</li>
</ul>
<p>购买 3 份报告</p>
<p>使用代码：</p>
<h4>Bundle25</h4>
<ul>
<li>
<h3>30% 折扣</h3>
</li>
</ul>
<p>购买 4 份报告</p>
<p>使用代码：</p>
<h4>Bundle30</h4>
<ul>
<li>
<h3>35% 折扣</h3>
</li>
</ul>
<p>购买 5 份及以上报告</p>
<p>使用代码：</p>
<h4>Bundle35</h4>
<p>适用于所有定价为 995 美元及以上的报告。不可与其他优惠叠加。</p>
<h4>仍在考虑什么最适合您的业务？</h4>
<p>请向我们的专家寻求帮助。</p>
<p>购买前咨询</p>

<p>全球临床试验公司已同意收购肿瘤临床研究公司 Catalyst Clinical Research，以增强其在肿瘤领域的能力并扩大其全球影响力。此次整合将把 Catalyst 的解决方案与全球公司的产品组合相结合，从而改善服务提供和运营效率。Catalyst 的董事长将加入全球公司的董事会，其首席执行官将成为全球公司的领导团队成员。此次收购尚待监管机构的批准，预计将在 2026 年第一季度完成</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2026/01/CTA-22-01-2026-shutterstock_2589155789-419x241.jpg" alt="" original-src="https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2026/01/CTA-22-01-2026-shutterstock_2589155789-419x241.jpg"/></p>
<p>The deal includes adopting complementary technology platforms and practices to enhance efficiency and visibility across development. Credit: PeopleImages / Shutterstock.com.</p>
<div class="lb-trans"><p>该交易包括采用互补的技术平台和实践，以提高开发过程中的效率和可见性。图片来源：PeopleImages / Shutterstock.com。</p>
</div><p>Worldwide Clinical Trials has entered a definitive agreement to acquire oncology contract research organisation (CRO) Catalyst Clinical Research.</p>
<div class="lb-trans"><p>Worldwide Clinical Trials 已达成最终协议，收购肿瘤学合同研究组织（CRO）Catalyst Clinical Research。</p>
</div><p>The transaction will see Catalyst Board chairman Nick Dyer join Worldwide’s board of directors while Catalyst president and CEO Nik Morton will become part of Worldwide’s executive leadership team.</p>
<div class="lb-trans"><p>此次交易将使 Catalyst 董事会主席 Nick Dyer 加入 Worldwide 的董事会，而 Catalyst 总裁兼首席执行官 Nik Morton 将成为 Worldwide 执行领导团队的一部分。</p>
</div><p>This acquisition aims to establish Worldwide as an oncology-focused CRO while maintaining depth in several therapeutic areas and expanding its global reach for clinical trials.</p>
<div class="lb-trans"><p>此次收购旨在将 Worldwide 建立为一家专注于肿瘤学的 CRO，同时在多个治疗领域保持深度，并扩大其在临床试验中的全球覆盖范围。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://hubspot-pmisites.pantheonsite.io/techmonitor/wp-content/themes/goodlife-wp-B2B/assets/images/icons/Module.png" alt="" original-src="https://hubspot-pmisites.pantheonsite.io/techmonitor/wp-content/themes/goodlife-wp-B2B/assets/images/icons/Module.png"/></p>
<p>Free Sample</p>
<div class="lb-trans"><p>免费样本</p>
</div><h3>Download sample pages of selected reports</h3>
<div class="lb-trans"><h3>下载精选报告的样本页面</h3>
</div><p>Explore a selection of report samples we have handpicked for you. Get a preview of the insights inside. Download your free copy today.</p>
<div class="lb-trans"><p>探索我们为您精心挑选的报告样本，提前预览其中的见解。今天就下载您的免费副本。</p>
</div><p>The integration will combine Catalyst’s solutions, Catalyst Flex and Catalyst Oncology, with Worldwide’s existing portfolio, offering customers expanded services for full-service, functional service provider (FSP) resourcing, and hybrid models.</p>
<div class="lb-trans"><p>此次整合将 Catalyst 的解决方案 Catalyst Flex 和 Catalyst Oncology 与 Worldwide 现有的产品组合相结合，为客户提供全面服务、功能性服务提供商（FSP）资源和混合模型的扩展服务。</p>
</div><p>Additionally, the deal includes the adoption of complementary technology platforms and operational practices to enhance data efficiency and visibility across the development lifecycle.</p>
<div class="lb-trans"><p>此外，该交易还包括采用互补的技术平台和运营实践，以提高开发生命周期中的数据效率和可见性。</p>
</div><p>Worldwide will acquire Catalyst for an undisclosed sum pending customary closing conditions and regulatory approvals. The transaction is expected to conclude in Q1 2026.</p>
<div class="lb-trans"><p>Worldwide 将以未披露的金额收购 Catalyst，待满足常规的成交条件和监管批准。预计交易将在 2026 年第一季度完成。</p>
</div><p>Worldwide is backed by Kohlberg while Catalyst is a portfolio company of QHP Capital. BofA Securities advised Catalyst exclusively; Smith Anderson was its legal counsel. Greenberg Traurig acted as legal counsel for Worldwide.</p>
<div class="lb-trans"><p>Worldwide 得到了 Kohlberg 的支持，而 Catalyst 是 QHP Capital 的投资组合公司。BofA Securities 独家为 Catalyst 提供咨询；Smith Anderson 是其法律顾问。Greenberg Traurig 为 Worldwide 提供法律顾问。</p>
</div><p>Worldwide CEO Alistair Macdonald said: “Bringing Worldwide and Catalyst together elevates our capabilities in oncology and provides a new solution for our collective customers.</p>
<div class="lb-trans"><p>Worldwide 首席执行官 Alistair Macdonald 表示：“将 Worldwide 和 Catalyst 结合在一起提升了我们在肿瘤学领域的能力，并为我们共同的客户提供了新的解决方案。</p>
</div><p>“We are excited to add Catalyst’s deep operational expertise and oncology credibility to our own well-known CNS specialist CRO capabilities to create a differentiated biotech-oriented oncology solution. Our combined customers seek focused senior executive connection and attention, predictability, speed, flexibility, and scientific rigour.</p>
<div class="lb-trans"><p>“我们很高兴将 Catalyst 深厚的运营专业知识和肿瘤学信誉与我们知名的中枢神经系统专业 CRO 能力相结合，创造出一个差异化的生物技术导向的肿瘤学解决方案。我们的共同客户寻求专注的高级管理人员的联系和关注、可预测性、速度、灵活性和科学严谨性。</p>
</div><p>“They will benefit from the addition of a scalable FSP model with integrated onshore/offshore service lines while we leverage advanced business management tools and AI to drive operational excellence.”</p>
<div class="lb-trans"><p>“他们将受益于可扩展的 FSP 模型的增加，该模型集成了本土/离岸服务线，同时我们利用先进的业务管理工具和人工智能推动运营卓越。”</p>
</div><p>In May 2024, Medidata announced an expanded partnership with Worldwide to expedite clinical trials and enhance the patient experience.</p>
<div class="lb-trans"><p>在 2024 年 5 月，Medidata 宣布与 Worldwide 扩大合作关系，以加快临床试验并提升患者体验。</p>
</div><h3>Unlock up to 35% savings on GlobalData reports</h3>
<div class="lb-trans"><h3>在 GlobalData 报告上解锁高达 35% 的折扣</h3>
</div><p>Use the code at checkout in the report store</p>
<div class="lb-trans"><p>在报告商店结账时使用代码</p>
</div><ul>
<li>
<h3>20% OFF</h3>
</li>
</ul>
<div class="lb-trans"><ul>
<li>
<h3>20% 折扣</h3>
</li>
</ul>
</div><p>Buy 2 reports</p>
<div class="lb-trans"><p>购买 2 份报告</p>
</div><p>Use code:</p>
<div class="lb-trans"><p>使用代码：</p>
</div><h4>Bundle20</h4>
<div class="lb-trans"><h4>Bundle20</h4>
</div><ul>
<li>
<h3>25% OFF</h3>
</li>
</ul>
<div class="lb-trans"><ul>
<li>
<h3>25% 折扣</h3>
</li>
</ul>
</div><p>Buy 3 reports</p>
<div class="lb-trans"><p>购买 3 份报告</p>
</div><p>Use code:</p>
<div class="lb-trans"><p>使用代码：</p>
</div><h4>Bundle25</h4>
<div class="lb-trans"><h4>Bundle25</h4>
</div><ul>
<li>
<h3>30% OFF</h3>
</li>
</ul>
<div class="lb-trans"><ul>
<li>
<h3>30% 折扣</h3>
</li>
</ul>
</div><p>Buy 4 reports</p>
<div class="lb-trans"><p>购买 4 份报告</p>
</div><p>Use code:</p>
<div class="lb-trans"><p>使用代码：</p>
</div><h4>Bundle30</h4>
<div class="lb-trans"><h4>Bundle30</h4>
</div><ul>
<li>
<h3>35% OFF</h3>
</li>
</ul>
<div class="lb-trans"><ul>
<li>
<h3>35% 折扣</h3>
</li>
</ul>
</div><p>Buy 5+ reports</p>
<div class="lb-trans"><p>购买 5 份及以上报告</p>
</div><p>Use code:</p>
<div class="lb-trans"><p>使用代码：</p>
</div><h4>Bundle35</h4>
<div class="lb-trans"><h4>Bundle35</h4>
</div><p>Valid on all reports priced $995 and above. Cannot be combined with other offers.</p>
<div class="lb-trans"><p>适用于所有定价为 995 美元及以上的报告。不可与其他优惠叠加。</p>
</div><h4>Still deciding what will work best for your business?</h4>
<div class="lb-trans"><h4>仍在考虑什么最适合您的业务？</h4>
</div><p>Ask our experts for help.</p>
<div class="lb-trans"><p>请向我们的专家寻求帮助。</p>
</div><p>Enquire before buying</p>
<div class="lb-trans"><p>购买前咨询</p>
</div>

Worldwide Clinical Trials 将收购 Catalyst